11. Dilemmas with Clinical Application of New Tools for Prenatal Genetic Screening and Testing
Feb. 3, 2016 8am - 2:30pm
- Participants will understand the differences between traditional and new genetic testing and screening modalities that can be offered to pregnant women to better inform them about their reproductive genetic risks
- Participants will gain knowledge about the techniques used for chromosomal microarray analysis and what the indications, counseling requirements, diagnostic yield and pitfalls are with use of CMA for prenatal diagnosis in pregnancies at high-risk and average-risk for aneuploidy and other genetic and genomic disorders.
- Participants will learn about the technology and diagnostic and screening applications of next-generation sequencing. They will be able to apply this knowledge for decision making and patient counseling on use of tests based on this technology, such as non-invasive cfDNA screening for aneuploidy, prenatal exome sequencing, expanded carrier screening, and non-invasive prenatal diagnosis for single gene disorders.
- Participants will learn new strategies to optimally integrate modern genetic screening and testing in their maternal-fetal medicine practice. These concepts will be illustrated with case-based examples.